K2bio

K2bio, a Preclinical Contract Research Organization (CRO) based in Houston, Texas, aims to enhance scientific research within the Biotechnology and Health Care industries. Established in 2021, the company's slogan "Enhance your research..." emphasizes its commitment to supporting in vivo and in vitro demands and providing regulatory oversight for pharmaceutical products. With a focus on delivering customized solutions, K2bio's team endeavors to ensure the generation of the most meaningful and accurate data. The most recent investment in K2bio amounted to $615.52K, which was secured through a Seed Round investment on 01 August 2023. The funding, albeit not associated with specific investors at this point, reflects a growing investor interest in the company's innovative offerings. As K2bio continues to establish itself as a prominent player in the field, this recent injection of funds is poised to further drive its initiatives and propel its growth in the competitive landscape of preclinical research.